JANUARY 27TH, 2022 CONN HASTINGS EXCLUSIVE, OPHTHALMOLOGY Sight Sciences, a medtech company based in California, specializes in devices to treat glaucoma and dry eye disease. The company has recently announced FDA 510(k) clearance for the TearCare System, a device designed to treat meibomian gland dysfunction. Meibomian glands are present near the rims of our eyelids and they...
